Design, synthesis, and docking study of new quinoline derivatives as antitumor agents
出版年份 2019 全文链接
标题
Design, synthesis, and docking study of new quinoline derivatives as antitumor agents
作者
关键词
-
出版物
ARCHIV DER PHARMAZIE
Volume -, Issue -, Pages e1800355
出版商
Wiley
发表日期
2019-05-13
DOI
10.1002/ardp.201800355
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- l H -Pyrazolo[3,4- b ]quinolin-3-amine derivatives inhibit growth of colon cancer cells via apoptosis and sub G1 cell cycle arrest
- (2018) Chandrabose Karthikeyan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cytotoxicity and molecular targeting study of novel 2-choro-3-substituted quinoline derivatives as antitumor agents
- (2018) Mohamed Massoud et al. Letters in Drug Design & Discovery
- Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis
- (2017) Zuyao Yang et al. INTERNATIONAL JOURNAL OF CANCER
- Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma
- (2017) Nizar M. Tannir et al. Current Oncology Reports
- Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function
- (2017) I. Kalhari Lindamulage et al. Scientific Reports
- Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives
- (2016) Xiaoqin Wang et al. MOLECULES
- Mutation of Gly717Phe in human topoisomerase 1B has an effect on enzymatic function, reactivity to the camptothecin anticancer drug and on the linker domain orientation
- (2015) Zhenxing Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Lenvatinib: First Global Approval
- (2015) Lesley J. Scott DRUGS
- A review on anticancer potential of bioactive heterocycle quinoline
- (2015) Obaid Afzal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
- (2015) Ken-ichi Fujita WORLD JOURNAL OF GASTROENTEROLOGY
- Schiff’s base derivatives bearing nitroimidazole and quinoline nuclei: New class of anticancer agents and potential EGFR tyrosine kinase inhibitors
- (2014) Jigar A. Makawana et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models
- (2013) Kiyoshi Okamoto et al. CANCER LETTERS
- Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells
- (2013) Claudia Y. Acevedo-Morantes et al. DRUG DELIVERY
- 4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities
- (2012) Ali Rafinejad et al. DARU-Journal of Pharmaceutical Sciences
- Quinoline as a Privileged Scaffold in Cancer Drug Discovery
- (2011) V. R. Solomon et al. CURRENT MEDICINAL CHEMISTRY
- First construction of 12H-thiochromeno[2,3-b]quinolines and 5H-benzo[7,8]thiocino-[2,3-b]quinolines via intramolecular Friedel–Crafts reaction of Morita–Baylis–Hillman adducts
- (2011) Weihui Zhong et al. TETRAHEDRON
- Synthesis and biological evaluation of tetrazole containing compounds as possible anticancer agents
- (2011) Chebolu Naga Sesha Sai Pavan Kumar et al. MedChemComm
- Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors
- (2010) Afshin Zarghi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Quinoline-Based Antifungals
- (2010) R. Musiol et al. CURRENT MEDICINAL CHEMISTRY
- Biological Activities of Quinoline Derivatives
- (2010) Suresh Kumar et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Preparation and reactions of 2-azidoquinoline-3-carboxaldehyde with primary amines and active methylene compounds
- (2009) Nabila M. Ibrahim et al. JOURNAL OF CHEMICAL RESEARCH
- Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria
- (2008) Maud Henry et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
- (2008) A. Vultur et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now